Journal profile · Medicine-General Medicine
International Journal of General Medicine
ISSN 1178-7074 · Dove Medical Press · NEW ZEALAND
International Journal of General Medicine: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.27; JCR Q2 (journal website); fully open access; APC about USD 3,940; median 84 days to acceptance (141 articles, last 24 months); acceptance rate 10% (journal website); 624 articles in 2025; indexed in SCIE and Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
International Journal of General Medicine is published by Dove Medical Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Ferroptosis and cancer prognosis, Inflammatory Biomarkers in Disease Prognosis and Sepsis Diagnosis and Treatment, together about 29.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Professor Kenneth Adler The International Journal of General Medicine is a peer-reviewed, open access journal that focuses on general and internal medicine. The journal showcases categorized research on diseases related to specific areas of the body, curated by a global team of experts within each area. Focus areas of the journal Specific topics covered by the journal include: Diagnosis and nonsurgical treatment of diseases Elucidation of disease processes and management protocols Patient perspectives including satisfaction, quality of life, health literacy and communication Development of new healthcare programs and optimizing clinical outcomes Improved patient outcomes Monitoring and treatment protocols Multi-system disease processes Prevention Pathogenesis Epidemiology Acceptable study types Clinical studies in all areas of human disease and medicine are welcomed. When considering submission of a paper utilizing publicly available data (e.g. SEER/GWAS/TCGA/GEO etc.), authors should ensure that such studies add significantly to the body of knowledge about a specific disease or relevant phenotype and that they are validated using the author’s own data through replication in an independent sample set and functional follow-up. Bioinformatics studies should also conform to these criteria. The International Journal of General Medicine will no longer consider meta-analyses for publication and bibliometric studies are not suitable for this journal. The journal will not consider research purely focusing on surgical techniques and research on cell lines or animal studies will be considered if they are used to model specific human diseases. Acceptable article types The International Journal of General Medicine is characterized by the rapid reporting of reviews, original research, and clinical studies across all disease areas. Case reports/series submitted to the International Journal of General Medicine will be diverted to the International Medical Case Reports Journal (Journal metric data for this journal can be accessed here) The journal welcomes submissions to the following sections: Allergy Cardiovascular Endocrinology Gastroenterology General Medicine Hematology Hepatology Infectious Diseases Nephrology Neurology Oncology Ophthalmology Public Health Pulmonary Medicine Regenerative Medicine Urology Updated 25 November 2025
From the journal's Aims & Scope
Research area (LetPub): Medicine-General Medicine
Editor-in-chief Kenneth AdlerPublisher website
Editorial board by country: 3 in mainland China (about 2%); most named United States 42, Italy 13, India 11, United Kingdom 9, Japan 8 (134 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Ferroptosis and cancer prognosisMedicine12.8%
- Inflammatory Biomarkers in Disease PrognosisMedicine9.8%
- Sepsis Diagnosis and TreatmentMedicine6.6%
- COVID-19 Clinical Research StudiesMedicine6.2%
- Cancer Immunotherapy and BiomarkersMedicine4.3%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology4.2%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine3.9%
- Nutrition and Health in AgingMedicine3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, General & Internal | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 3 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusDOAJLetPub
Early warning / risk: CAS Early Warning Journal List: listed in the 2021 edition (low risk); not listed in the other 5 editions.LetPub
Indexing the journal's website claims
PubMedPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.27LetPub ·
- Impact factor (publisher) 2025
- 2.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.4Publisher website ·
- CiteScore 2026-06
- 2.2LetPub ·
- SJR 2026-06
- 0.52LetPub ·
- SNIP 2026-06
- 0.65LetPub ·
- h-index
- 80OpenAlex ·
- i10-index
- 1,612OpenAlex ·
- 2-year mean citedness
- 2.44OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 99.17%LetPub ·
Volume
- Articles per year
- 604LetPub ·
- Downloads per year (publisher)
- 647,507Publisher website ·
Articles by year OpenAlex count · 5,022 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 478 | 478 | 92 |
| 2025 | 624 | 624 | 1,241 |
| 2024 | 581 | 581 | 2,772 |
| 2023 | 542 | 542 | 4,073 |
| 2022 | 764 | 764 | 8,100 |
| 2021 | 990 | 990 | 14,448 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
84 daysMedian, submission to acceptance · P25–P75 65 days – 101 days
- Acceptance to online
- median 16 days (141 articles)
- Submission to online
- median 102 days
- Sample
- 141 articles with submission and acceptance dates (1,278 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Acceptance rate (publisher)
- 10%Publisher website ·
- Desk decision
- 50 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,940 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,836 | — | — | |
| LetPub | USD 2,990 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
- reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dove Medical Press
- Country or region
- NEW ZEALAND
- Language
- English
- ISSN
- 1178-7074
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about International Journal of General Medicine
What CAS zone is International Journal of General Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, International Journal of General Medicine is in Zone 4 of Medicine, and in Zone 3 of the minor category Medicine, General & Internal. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of International Journal of General Medicine?
The latest impact factor listed by LetPub is 2.27; CiteScore 2.2, h-index 80.
How long does peer review take at International Journal of General Medicine?
Based on the dates recorded on 141 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 84 days (interquartile range 65–101 days); authors report an average review time of about 16 weeks; the journal's website gives an acceptance rate of 10%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is International Journal of General Medicine in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Where are the editorial board members of International Journal of General Medicine based?
Of the 134 board members whose country the journal's board page names, 3 (about 2%) are in mainland China; the countries named most often are United States (42), Italy (13) and India (11). Counted from the institutions listed on the board page; for reference only.
Which databases index International Journal of General Medicine?
According to LetPub and DOAJ records, International Journal of General Medicine is indexed in SCIE, Scopus and DOAJ. The journal's website also lists PubMed; that list has not been checked against each database.
Is International Journal of General Medicine open access, and what is the APC?
International Journal of General Medicine is a fully open-access journal. APC about USD 3,940.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .